NIH Obesity Research Task Force Symposium: Obesity and Heart Disease Webinar

Obesity contributes to diseases of the heart—including atherosclerotic cardiovascular disease, arrhythmias, and heart failure with preserved ejection fraction—which often are refractory to treatment. This symposium explores the epidemiology and pathophysiology of obesity-related heart diseases, as well as the role of emerging therapeutics and issues related to prevention, access to treatment, and health equity.

For more information, visit niddk.nih.gov.

00:00 Welcoming Remarks
Gary Gibbons, M.D., Director, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH)

4:22 Epidemiology of Heart Disease in Persons with Obesity
Sadiya Khan, M.D., M.Sc., Northwestern University

39:00 Fibrosis: A Final Common Pathway for Cardiovascular-Kidney-Metabolic Disease
Philipp Scherer, Ph.D., The University of Texas Southwestern Medical Center

1:18:16 Obesity and Cardiac Arrhythmias
Alvaro Alonso, M.D., Ph.D., Emory University

1:51:00 Nutrient-stimulated Hormone-based Therapies in the Prevention of Obesity-related Cardiovascular Disease
A. Michael Lincoff, M.D., Cleveland Clinic

2:23:23 Obesity and Heart Failure with Preserved Ejection Fraction Pathophysiology and Treatment
Barry Borlaug, M.D., Mayo Clinic

2:56:46 The Role of Obesity on Cardiovascular Disease Risk in Pregnant and Postmenopausal Women
Imo Ebong, M.D., University of California, Davis

3:29:25 Health Disparities and Health Equity in Patients with Obesity and Heart Disease
Tiffany Powell-Wiley, M.D., M.P.H., NHLBI, NIH

3:59:25 Panel Discussion
Moderator: Eric Shiroma, Sc.D., NHLBI, NIH